{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T21:54:38Z","timestamp":1772229278676,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Paraneoplastic limbic encephalitis (PLE) is a rare autoimmune neurological syndrome observed in lung cancer patients. We retrospectively investigated the clinical characteristics, treatment responses, and prognoses in 16 PLE patients who were subsequently diagnosed with lung cancer. Fifteen patients initially presented with disturbance of consciousness, 13 with disorientation, and 12 with seizures. Thirteen patients had autoantibodies, including eight with gamma aminobutyric acid B receptor (GABA<jats:sub>B<\/jats:sub>R) antibodies and eight with Hu antibodies. PET-CT revealed lung neoplasms in 13 patients, nine of whom exhibited abnormal metabolic activity in the temporal lobe and hippocampus. Fifteen cases were confirmed as limited-stage small cell lung cancer and one as stage IV large cell neuroendocrine carcinoma. Eleven patients received immunomodulatory therapy, and four showed neurological improvement, who all had antibodies against GABA<jats:sub>B<\/jats:sub>R. Fifteen patients received chemotherapy, of which 14 maintained or improved their PLE status. The overall cancer response rate was 75%, and two-year overall survival was 74.7%. Our results suggest patients with GABA<jats:sub>B<\/jats:sub> encephalitis might respond better to immunotherapy than the classical PLE patients with anti-Hu antibodies. Anti-cancer treatment could further improve neurological symptoms. Lung cancer patients with PLE, especially those in limited stage, might have better outcome due to earlier diagnosis and prompt anti-cancer treatment.<\/jats:p>","DOI":"10.1038\/s41598-018-25294-y","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T09:19:19Z","timestamp":1524647959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Paraneoplastic limbic encephalitis associated with lung cancer"],"prefix":"10.1038","volume":"8","author":[{"given":"Kaini","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongzhi","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minjiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengzhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,1]]},"reference":[{"issue":"Pt 7","key":"25294_CR1","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1093\/brain\/123.7.1481","volume":"123","author":"SH Gultekin","year":"2000","unstructured":"Gultekin, S. H. et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain: a journal of neurology 123(Pt 7), 1481\u20131494 (2000).","journal-title":"Brain: a journal of neurology"},{"key":"25294_CR2","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/brain\/124.6.1138","volume":"124","author":"F Graus","year":"2001","unstructured":"Graus, F. et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain: a journal of neurology 124, 1138\u20131148 (2001).","journal-title":"Brain: a journal of neurology"},{"key":"25294_CR3","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1212\/01.WNL.0000085873.45099.E2","volume":"61","author":"R Scheid","year":"2003","unstructured":"Scheid, R. et al. Neuropsychiatric findings in anti-Ma2-positive paraneoplastic limbic encephalitis. Neurology 61, 1159\u20131161 (2003).","journal-title":"Neurology"},{"key":"25294_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1212\/WNL.0000000000001721","volume":"85","author":"P Gozzard","year":"2015","unstructured":"Gozzard, P. et al. Paraneoplastic neurologic disorders in small cell lung carcinoma: A prospective study. Neurology 85, 235\u2013239, https:\/\/doi.org\/10.1212\/WNL.0000000000001721 (2015).","journal-title":"Neurology"},{"key":"25294_CR5","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00415-009-5431-9","volume":"257","author":"F Graus","year":"2010","unstructured":"Graus, F., Saiz, A. & Dalmau, J. Antibodies and neuronal autoimmune disorders of the CNS. Journal of neurology 257, 509\u2013517, https:\/\/doi.org\/10.1007\/s00415-009-5431-9 (2010).","journal-title":"Journal of neurology"},{"key":"25294_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/1756285611405395","volume":"4","author":"W Grisold","year":"2011","unstructured":"Grisold, W., Giometto, B., Vitaliani, R. & Oberndorfer, S. Current approaches to the treatment of paraneoplastic encephalitis. Therapeutic advances in neurological disorders 4, 237\u2013248, https:\/\/doi.org\/10.1177\/1756285611405395 (2011).","journal-title":"Therapeutic advances in neurological disorders"},{"key":"25294_CR7","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1212\/WNL.0b013e3182a9585f","volume":"81","author":"R Hoftberger","year":"2013","unstructured":"Hoftberger, R. et al. Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology 81, 1500\u20131506, https:\/\/doi.org\/10.1212\/WNL.0b013e3182a9585f (2013).","journal-title":"Neurology"},{"key":"25294_CR8","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.3174\/ajnr.A5086","volume":"38","author":"BP Kelley","year":"2017","unstructured":"Kelley, B. P. et al. Autoimmune Encephalitis: Pathophysiology and Imaging Review of an Overlooked Diagnosis. AJNR Am J Neuroradiol 38, 1070\u20131078, https:\/\/doi.org\/10.3174\/ajnr.A5086 (2017).","journal-title":"AJNR Am J Neuroradiol"},{"key":"25294_CR9","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1001\/jamaneurol.2016.1399","volume":"73","author":"TJ Williams","year":"2016","unstructured":"Williams, T. J. et al. Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer. JAMA neurology 73, 928\u2013933, https:\/\/doi.org\/10.1001\/jamaneurol.2016.1399 (2016).","journal-title":"JAMA neurology"},{"key":"25294_CR10","doi-asserted-by":"publisher","unstructured":"Fellner, A. et al. Neurologic complications of immune checkpoint inhibitors. Journal of neuro-oncology, https:\/\/doi.org\/10.1007\/s11060-018-2752-5 (2018).","DOI":"10.1007\/s11060-018-2752-5"},{"key":"25294_CR11","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S1474-4422(02)00135-7","volume":"1","author":"R Voltz","year":"2002","unstructured":"Voltz, R. Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy. The Lancet. Neurology 1, 294\u2013305 (2002).","journal-title":"The Lancet. Neurology"},{"key":"25294_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus, F. et al. A clinical approach to diagnosis of autoimmune encephalitis. The Lancet. Neurology 15, 391\u2013404, https:\/\/doi.org\/10.1016\/S1474-4422(15)00401-9 (2016).","journal-title":"The Lancet. Neurology"},{"key":"25294_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.yebeh.2016.04.046","volume":"61","author":"A Serafini","year":"2016","unstructured":"Serafini, A. et al. Paraneoplastic epilepsy. Epilepsy Behav 61, 51\u201358, https:\/\/doi.org\/10.1016\/j.yebeh.2016.04.046 (2016).","journal-title":"Epilepsy Behav"},{"key":"25294_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jneuroim.2014.02.011","volume":"270","author":"TJ Kim","year":"2014","unstructured":"Kim, T. J. et al. Clinical manifestations and outcomes of the treatment of patients with GABAB encephalitis. Journal of neuroimmunology 270, 45\u201350, https:\/\/doi.org\/10.1016\/j.jneuroim.2014.02.011 (2014).","journal-title":"Journal of neuroimmunology"},{"key":"25294_CR15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3389\/fneur.2017.00584","volume":"8","author":"S Liao","year":"2017","unstructured":"Liao, S. et al. Clinical Characteristics and Predictors of Outcome for Onconeural Antibody-Associated Disorders: A Retrospective Analysis. Front Neurol 8, 584, https:\/\/doi.org\/10.3389\/fneur.2017.00584 (2017).","journal-title":"Front Neurol"},{"key":"25294_CR16","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.conb.2007.04.001","volume":"17","author":"D Ulrich","year":"2007","unstructured":"Ulrich, D. & Bettler, B. GABA(B) receptors: synaptic functions and mechanisms of diversity. Curr Opin Neurobiol 17, 298\u2013303, https:\/\/doi.org\/10.1016\/j.conb.2007.04.001 (2007).","journal-title":"Curr Opin Neurobiol"},{"key":"25294_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","volume":"9","author":"E Lancaster","year":"2010","unstructured":"Lancaster, E. et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. The Lancet. Neurology 9, 67\u201376, https:\/\/doi.org\/10.1016\/s1474-4422(09)70324-2 (2010).","journal-title":"The Lancet. Neurology"},{"key":"25294_CR18","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1212\/WNL.0b013e31820e7b8d","volume":"76","author":"A Boronat","year":"2011","unstructured":"Boronat, A., Sabater, L., Saiz, A., Dalmau, J. & Graus, F. GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology 76, 795\u2013800, https:\/\/doi.org\/10.1212\/WNL.0b013e31820e7b8d (2011).","journal-title":"Neurology"},{"key":"25294_CR19","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1586\/14737175.2015.1115720","volume":"15","author":"M Nosadini","year":"2015","unstructured":"Nosadini, M., Mohammad, S. S., Ramanathan, S., Brilot, F. & Dale, R. C. Immune therapy in autoimmune encephalitis: a systematic review. Expert review of neurotherapeutics 15, 1391\u20131419, https:\/\/doi.org\/10.1586\/14737175.2015.1115720 (2015).","journal-title":"Expert review of neurotherapeutics"},{"key":"25294_CR20","doi-asserted-by":"publisher","unstructured":"Stinchcombe, T. E. Current Treatments for Surgically Resectable, Limited-Stage, and Extensive-Stage Small Cell Lung Cancer. The oncologist, https:\/\/doi.org\/10.1634\/theoncologist.2017-0204 (2017).","DOI":"10.1634\/theoncologist.2017-0204"},{"key":"25294_CR21","doi-asserted-by":"publisher","unstructured":"Glatzer, M. et al. Treatment of limited disease small cell lung cancer: the multidisciplinary team. The European respiratory journal 50, https:\/\/doi.org\/10.1183\/13993003.00422-2017 (2017).","DOI":"10.1183\/13993003.00422-2017"},{"key":"25294_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-8-119","volume":"8","author":"K Kaira","year":"2014","unstructured":"Kaira, K. et al. Small-cell lung cancer with voltage-gated calcium channel antibody-positive paraneoplastic limbic encephalitis: a case report. Journal of medical case reports 8, 119, https:\/\/doi.org\/10.1186\/1752-1947-8-119 (2014).","journal-title":"Journal of medical case reports"},{"key":"25294_CR23","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1136\/jnnp.2006.102467","volume":"78","author":"L Zuliani","year":"2007","unstructured":"Zuliani, L. et al. Paraneoplastic limbic encephalitis associated with potassium channel antibodies: value of anti-glial nuclear antibodies in identifying the tumour. Journal of neurology, neurosurgery, and psychiatry 78, 204\u2013205, https:\/\/doi.org\/10.1136\/jnnp.2006.102467 (2007).","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"key":"25294_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/jnnp.71.1.40","volume":"71","author":"TH Bak","year":"2001","unstructured":"Bak, T. H., Antoun, N., Balan, K. K. & Hodges, J. R. Memory lost, memory regained: neuropsychological findings and neuroimaging in two cases of paraneoplastic limbic encephalitis with radically different outcomes. Journal of neurology, neurosurgery, and psychiatry 71, 40\u201347 (2001).","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"key":"25294_CR25","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.4103\/0366-6999.168989","volume":"128","author":"HZ Guan","year":"2015","unstructured":"Guan, H. Z. et al. Limbic Encephalitis Associated with Anti-gamma-aminobutyric Acid B Receptor Antibodies: A Case Series from China. Chinese medical journal 128, 3023\u20133028, https:\/\/doi.org\/10.4103\/0366-6999.168989 (2015).","journal-title":"Chinese medical journal"},{"key":"25294_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0140-6736(93)92485-C","volume":"341","author":"RB Darnell","year":"1993","unstructured":"Darnell, R. B. & DeAngelis, L. M. Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies. Lancet 341, 21\u201322 (1993).","journal-title":"Lancet"},{"key":"25294_CR27","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus, F. et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. Journal of neurology, neurosurgery, and psychiatry 75, 1135\u20131140, https:\/\/doi.org\/10.1136\/jnnp.2003.034447 (2004).","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"key":"25294_CR28","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1378\/chest.08-0978","volume":"136","author":"FC Detterbeck","year":"2009","unstructured":"Detterbeck, F. C., Boffa, D. J. & Tanoue, L. T. The new lung cancer staging system. Chest 136, 260\u2013271, https:\/\/doi.org\/10.1378\/chest.08-0978 (2009).","journal-title":"Chest"},{"key":"25294_CR29","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1097\/JTO.0b013e31812d05d5","volume":"2","author":"PA Groome","year":"2007","unstructured":"Groome, P. A. et al. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer 2, 694\u2013705, https:\/\/doi.org\/10.1097\/JTO.0b013e31812d05d5 (2007).","journal-title":"Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25294-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25294-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25294-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:46:30Z","timestamp":1671597990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25294-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["25294"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-25294-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,1]]},"assertion":[{"value":"13 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6792"}}